Details
Title
Transcriptome‐wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma
Author
Yong‐Qiao He 1 ; Wen‐Qiong Xue 1 ; Dan‐Hua Li 1 ; Tong‐Min Wang 1 ; Zhi‐Ming Mai 2 ; Da‐Wei Yang 3 ; Chang‐Mi Deng 1 ; Liao, Ying 1 ; Wen‐Li Zhang 1 ; Ruo‐Wen Xiao 1 ; Luo, Luting 3 ; Diao, Hua 3 ; Tong, Xiating 3 ; Wu, Yanxia 1 ; Jiang‐Bo Zhang 1 ; Zhou, Ting 1
; Xi‐Zhao Li 1 ; Pei‐Fen Zhang 1 ; Xiao‐Hui Zheng 1 ; Shao‐Dan Zhang 1 ; Ye‐Zhu Hu 1 ; Tang, Minzhong 4 ; Zheng, Yuming 4 ; Cai, Yonglin 4 ; Chang, Ellen T 5 ; Zhang, Zhe 6 ; Huang, Guangwu 6 ; Su‐Mei Cao 1 ; Liu, Qing 1 ; Lin, Feng 1 ; Sun, Ying 7
; Maria Li Lung 8 ; Hans‐Olov Adami 9 ; Ye, Weimin 10 ; Tai‐Hing Lam 11 ; Wei‐Hua Jia 12
1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat‐sen University Cancer Center, Guangzhou, Guangdong, P. R. China
2 School of Public Health, The University of Hong Kong, Hong Kong S.A.R., P. R. China; Center for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong S.A.R., P. R. China; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
3 School of Public Health, Sun Yat‐sen University, Guangzhou, Guangdong, P. R. China
4 Wuzhou Red Cross Hospital, Wuzhou, Guangxi, P. R. China; Wuzhou Cancer Center, Wuzhou, Guangxi, P. R. China
5 Center for Health Sciences, Exponent, Inc., Menlo Park, CA, 94025, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
6 Department of Otolaryngology‐Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P. R. China
7 Department of Radiation Oncology, Sun Yat‐sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, P. R. China
8 Center for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong S.A.R., P. R. China; Department of Clinical Oncology, The University of Hong Kong, Hong Kong S.A.R., P. R. China
9 Clinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
10 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology and Health Statistics & Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, P. R. China
11 School of Public Health, The University of Hong Kong, Hong Kong S.A.R., P. R. China; Center for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong S.A.R., P. R. China
12 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat‐sen University Cancer Center, Guangzhou, Guangdong, P. R. China; School of Public Health, Sun Yat‐sen University, Guangzhou, Guangdong, P. R. China
; Xi‐Zhao Li 1 ; Pei‐Fen Zhang 1 ; Xiao‐Hui Zheng 1 ; Shao‐Dan Zhang 1 ; Ye‐Zhu Hu 1 ; Tang, Minzhong 4 ; Zheng, Yuming 4 ; Cai, Yonglin 4 ; Chang, Ellen T 5 ; Zhang, Zhe 6 ; Huang, Guangwu 6 ; Su‐Mei Cao 1 ; Liu, Qing 1 ; Lin, Feng 1 ; Sun, Ying 7
; Maria Li Lung 8 ; Hans‐Olov Adami 9 ; Ye, Weimin 10 ; Tai‐Hing Lam 11 ; Wei‐Hua Jia 12
1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat‐sen University Cancer Center, Guangzhou, Guangdong, P. R. China
2 School of Public Health, The University of Hong Kong, Hong Kong S.A.R., P. R. China; Center for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong S.A.R., P. R. China; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
3 School of Public Health, Sun Yat‐sen University, Guangzhou, Guangdong, P. R. China
4 Wuzhou Red Cross Hospital, Wuzhou, Guangxi, P. R. China; Wuzhou Cancer Center, Wuzhou, Guangxi, P. R. China
5 Center for Health Sciences, Exponent, Inc., Menlo Park, CA, 94025, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
6 Department of Otolaryngology‐Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P. R. China
7 Department of Radiation Oncology, Sun Yat‐sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, P. R. China
8 Center for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong S.A.R., P. R. China; Department of Clinical Oncology, The University of Hong Kong, Hong Kong S.A.R., P. R. China
9 Clinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
10 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology and Health Statistics & Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, P. R. China
11 School of Public Health, The University of Hong Kong, Hong Kong S.A.R., P. R. China; Center for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong S.A.R., P. R. China
12 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat‐sen University Cancer Center, Guangzhou, Guangdong, P. R. China; School of Public Health, Sun Yat‐sen University, Guangzhou, Guangdong, P. R. China
Pages
887-891
Section
LETTERS TO THE EDITOR
Publication year
2022
Publication date
Sep 2022
e-ISSN
2523-3548
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2711550556
Copyright
© 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.